The effects of subcutaneous and endolymphatic tactivin (in doses of 1 ml of 0.01% solution daily for 7 days) on clinical and immunological parameters were studied in patients with acute inflammations in the maxillofacial area, running a normo-, hypo-, and hyperergic course. Tactivin accelerated the arrest of inflammatory process and improved the patients' status, particularly so in cases with the hypo- and hyperergic inflammations. The key role in the mechanism of the drug action is played by increase of the immunoregulatory index, which reflects the increasing resistance of the body.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
hypo- hyperergic
8
[indications tactivin
4
tactivin combined
4
combined treatment
4
treatment phlegmons
4
phlegmons maxillofacial
4
maxillofacial area]
4
area] effects
4
effects subcutaneous
4
subcutaneous endolymphatic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!